PROCEPT BioRobotics Corp. (PRCT)
20.62
+0.35
(+1.73%)
USD |
NASDAQ |
Nov 06, 16:00
20.62
0.00 (0.00%)
After-Hours: 16:37
PROCEPT BioRobotics Research and Development Expense (Annual) : 71.28M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 71.28M |
| December 31, 2024 | 62.30M |
| December 31, 2023 | 48.45M |
| December 31, 2022 | 28.98M |
| Date | Value |
|---|---|
| December 31, 2021 | 18.99M |
| December 31, 2020 | 16.28M |
| December 31, 2019 | 13.15M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Insulet Corp. | 301.10M |
| Beta Bionics, Inc. | 34.79M |
| Abbott Laboratories | 2.889B |
| Baxter International, Inc. | 503.00M |
| Becton, Dickinson & Co. | 988.00M |